
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14743741
[patent_doc_number] => 20190255044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => TREATMENT AND PROGNOSTIC MONITORING OF PROLIFERATION DISORDERS USING HEDGEHOG PATHWAY INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/398756
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/398756 | TREATMENT AND PROGNOSTIC MONITORING OF PROLIFERATION DISORDERS USING HEDGEHOG PATHWAY INHIBITORS | Apr 29, 2019 | Abandoned |
Array
(
[id] => 16612065
[patent_doc_number] => 20210030718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => COMBINATIONS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/047931
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047931
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047931 | COMBINATIONS FOR TREATING CANCER | Apr 28, 2019 | Abandoned |
Array
(
[id] => 15035471
[patent_doc_number] => 20190328740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => Cancer Treatment Targeted to Tumor Adaptive Responses to Protein Synthesis Stress
[patent_app_type] => utility
[patent_app_number] => 16/396723
[patent_app_country] => US
[patent_app_date] => 2019-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396723
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/396723 | Cancer treatment targeted to tumor adaptive responses to protein synthesis stress | Apr 27, 2019 | Issued |
Array
(
[id] => 15975483
[patent_doc_number] => 10668042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Methods of reducing the risk of cardiovascular events in a subject
[patent_app_type] => utility
[patent_app_number] => 16/391128
[patent_app_country] => US
[patent_app_date] => 2019-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 56
[patent_no_of_words] => 60653
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16391128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/391128 | Methods of reducing the risk of cardiovascular events in a subject | Apr 21, 2019 | Issued |
Array
(
[id] => 16711892
[patent_doc_number] => 20210079039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => COMPOSITIONS AND METHODS FOR THE SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/048078
[patent_app_country] => US
[patent_app_date] => 2019-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048078 | COMPOSITIONS AND METHODS FOR THE SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS | Apr 15, 2019 | Abandoned |
Array
(
[id] => 14649327
[patent_doc_number] => 20190231792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 16/374081
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16374081
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/374081 | Pharmaceutical compositions comprising meloxicam | Apr 2, 2019 | Issued |
Array
(
[id] => 15604147
[patent_doc_number] => 10583113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Cromolyn compositions for treatment of pulmonary fibrosis
[patent_app_type] => utility
[patent_app_number] => 16/370677
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 53231
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370677
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/370677 | Cromolyn compositions for treatment of pulmonary fibrosis | Mar 28, 2019 | Issued |
Array
(
[id] => 15510137
[patent_doc_number] => 10561635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Cromolyn compositions for treatment of pulmonary fibrosis
[patent_app_type] => utility
[patent_app_number] => 16/370681
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 53239
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370681
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/370681 | Cromolyn compositions for treatment of pulmonary fibrosis | Mar 28, 2019 | Issued |
Array
(
[id] => 14896857
[patent_doc_number] => 20190292194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => INHIBITORS OF ERK AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/370718
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 145190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370718
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/370718 | INHIBITORS OF ERK AND METHODS OF USE | Mar 28, 2019 | Abandoned |
Array
(
[id] => 14578397
[patent_doc_number] => 20190216807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/360693
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360693 | COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS | Mar 20, 2019 | Abandoned |
Array
(
[id] => 16381904
[patent_doc_number] => 10806714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Compositions and methods of use of phorbol esters in the treatment of neoplasms
[patent_app_type] => utility
[patent_app_number] => 16/360139
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17604
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360139
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360139 | Compositions and methods of use of phorbol esters in the treatment of neoplasms | Mar 20, 2019 | Issued |
Array
(
[id] => 16428233
[patent_doc_number] => 10828294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Compositions and methods for weight loss in at risk patient populations
[patent_app_type] => utility
[patent_app_number] => 16/356657
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6628
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356657
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/356657 | Compositions and methods for weight loss in at risk patient populations | Mar 17, 2019 | Issued |
Array
(
[id] => 14990811
[patent_doc_number] => 20190314363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Compositions And Methods For Reducing Major Adverse Cardiovascular Events
[patent_app_type] => utility
[patent_app_number] => 16/356663
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356663
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/356663 | Compositions and methods for reducing major adverse cardiovascular events | Mar 17, 2019 | Issued |
Array
(
[id] => 14833283
[patent_doc_number] => 20190275042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => FLUOROCYCLOPENTENYLCYTOSINE METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/356328
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/356328 | FLUOROCYCLOPENTENYLCYTOSINE METHODS OF USE | Mar 17, 2019 | Abandoned |
Array
(
[id] => 16498854
[patent_doc_number] => 10864221
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-12-15
[patent_title] => Neuroprotective mixture for mitigating the harmful effects of ischemic stroke
[patent_app_type] => utility
[patent_app_number] => 16/354994
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 3776
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16354994
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/354994 | Neuroprotective mixture for mitigating the harmful effects of ischemic stroke | Mar 14, 2019 | Issued |
Array
(
[id] => 14929729
[patent_doc_number] => 20190300502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/299722
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299722
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299722 | SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS | Mar 11, 2019 | Abandoned |
Array
(
[id] => 16555647
[patent_doc_number] => 20210000795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => ERGOTHIONEINE COMPOSITIONS AND METHODS FOR MAINTAINING AND/OR INCREASING VITAMIN C LEVELS IN CELLS AND ORGANISMS
[patent_app_type] => utility
[patent_app_number] => 16/978673
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978673
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/978673 | Ergothioneine compositions and methods for maintaining and/or increasing vitamin C levels in cells and organisms | Feb 28, 2019 | Issued |
Array
(
[id] => 16282597
[patent_doc_number] => 20200276199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/289515
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289515
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289515 | INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS | Feb 27, 2019 | Abandoned |
Array
(
[id] => 14893695
[patent_doc_number] => 20190290613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING
[patent_app_type] => utility
[patent_app_number] => 16/283985
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/283985 | Use of indole compounds for fat reduction and skin and soft tissue tightening | Feb 24, 2019 | Issued |
Array
(
[id] => 14464395
[patent_doc_number] => 20190183837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => COMPOSITIONS AND METHODS OF USE OF PHORBOLESTERS
[patent_app_type] => utility
[patent_app_number] => 16/284461
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284461
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/284461 | Compositions and methods of use of phorbolesters | Feb 24, 2019 | Issued |